![These highlights do not include all the information needed to use budesonide inhalation suspension safely and effectively. See full prescribing information for budesonide inhalation suspension.BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 These highlights do not include all the information needed to use budesonide inhalation suspension safely and effectively. See full prescribing information for budesonide inhalation suspension.BUDESONIDE inhalation suspension Initial U.S. Approval: 2000](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=NDC+68258-8922-05------TEVA.jpg&id=104851)
These highlights do not include all the information needed to use budesonide inhalation suspension safely and effectively. See full prescribing information for budesonide inhalation suspension.BUDESONIDE inhalation suspension Initial U.S. Approval: 2000
![PDF) Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/- charcoal [char] block) in healthy volunteers (HV) | Gokul Gopalan - Academia.edu PDF) Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/- charcoal [char] block) in healthy volunteers (HV) | Gokul Gopalan - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/53650728/mini_magick20190120-19550-10bqm6.png?1547979346)
PDF) Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/- charcoal [char] block) in healthy volunteers (HV) | Gokul Gopalan - Academia.edu
![Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c8a53fd8-7246-40de-acd7-9d497f8dee0c/gr1_lrg.gif)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Research roundup: Budesonide-formoterol used as needed to prevent asthma exacerbations: a trial reflecting real-world practice | Let's Talk Respiratory - Let's Talk Respiratory Research roundup: Budesonide-formoterol used as needed to prevent asthma exacerbations: a trial reflecting real-world practice | Let's Talk Respiratory - Let's Talk Respiratory](http://letstalkrespiratory.ie/wp-content/uploads/2020/10/GettyImages-1090820390-scaled-1600x720-c-center.jpg)
Research roundup: Budesonide-formoterol used as needed to prevent asthma exacerbations: a trial reflecting real-world practice | Let's Talk Respiratory - Let's Talk Respiratory
![Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler - ScienceDirect Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517315005050-fx1.jpg)
Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler - ScienceDirect
![Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d3018e26-bf9f-4dbf-8b5b-07990f6c8c6d/gr1.jpg)